{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:59:49Z","timestamp":1794013189582,"version":"4.8.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>PET-Magnetic Resonance (PET-MR) imaging is an upcoming investigative modality with a few installations in Asia and only three in India. PET-Computed Tomography (PET-CT) is an established diagnostic cornerstone for oncological indications but with limited resolution for small lesions due to low soft-tissue contrast and additional radiation exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Our primary objective was to evaluate the diagnostic performance of simultaneous PET-MR and PET-CT in lesion detection in oncological practice. Secondly to assess the referral pattern and study the clinical utility of PET-MR in a university hospital practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>A total of 100 consecutive biopsy-proven cancer patients (breast or lung malignancy with suspected metastases) underwent <jats:sup>18<\/jats:sup>F Fluorodeoxyglucose (FDG) PET-MR and PET-CT for staging as a single injection, double examination protocol. Morphological lesion detection on correlative imaging\/histopathology was used as the gold standard. Analysing the referral pattern, a total of 9366 patients underwent simultaneous PET-MR imaging for various indications in the past 5 years since installation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F FDG PET-MR detected 100% of primary tumours in breast\/lung carcinoma patients while PET-CT was positive in 96%. Overall accuracy of nodal metastases detection for PET-MR and PET-CT was 96 and 88%, while for distant metastases the accuracy was 100 and 93%, respectively. FDG PET-MR proved more sensitive and specific than PET-CT for regional nodal (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.011 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001) and distant metastases detection (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.017 and <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, respectively). Analysing the general referral pattern for PET-MR, the majority were oncology referrals when compared to nononcological indications (66.5, 33.5%). About 66.24% were FDG based, followed by <jats:sup>68<\/jats:sup>Ga Prostate-Specific Membrane Antigen (PSMA) and dodecane tetraacetic acid (DOTA). The general utility of PET-MR was found incremental in better delineation of small lesions especially in head, neck, liver, brain and gynaecological malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In our past 5 years of PET-MR practice, we found that simultaneous PET-MR is a highly recommended ideal imaging technique for oncological and nononcological indications. It has excellent diagnostic performance with high sensitivity, specificity and accuracy when compared to PET-CT in primary tumour, nodal and distant metastases (TNM) staging in specific subgroup of breast and lung malignancy patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001900","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:55:15Z","timestamp":1727351715000},"page":"1022-1032","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic performance of simultaneous PET-MR versus PET-CT in oncology with an overview on clinical utility and referral pattern of PET-MR: a single institutional study"],"prefix":"10.1097","volume":"45","author":[{"given":"Shanmuga Sundaram","family":"Palaniswamy","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine & Molecular Imaging, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Cochin, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Subramanyam","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine & Molecular Imaging, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Cochin, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"R1-20250807","doi-asserted-by":"crossref","first-page":"011013","DOI":"10.1117\/1.JMI.4.1.011013","article-title":"History and future technical innovation in positron emission tomography.","volume":"4","author":"Jones","year":"2017","journal-title":"J Med Imaging (Bellingham)"},{"key":"R2-20250807","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/jpm10040284","article-title":"Whole body 3.0 T magnetic resonance imaging in lymphomas: comparison of different sequence combinations for staging Hodgkin\u2019s and diffuse large B cell lymphomas.","volume":"10","author":"Latifoltojar","year":"2020","journal-title":"J Pers Med"},{"key":"R3-20250807","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1102\/1470-7330.2009.0017","article-title":"Nodal staging.","volume":"9","author":"Ganeshalingam","year":"2009","journal-title":"Cancer Imaging"},{"key":"R4-20250807","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"R5-20250807","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/RTI.0000000000000140","article-title":"Lung nodule and cancer detection in computed tomography screening.","volume":"30","author":"Rubin","year":"2015","journal-title":"J Thorac Imaging"},{"key":"R6-20250807","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1522-2586(199905)9:5<691::AID-JMRI11>3.0.CO;2-7","article-title":"MR imaging of focal lung lesions: elimination of flow and motion artifact by breath-hold ECG-gated and black-blood techniques on T2-weighted turbo SE and STIR sequences.","volume":"9","author":"Yamashita","year":"1999","journal-title":"J Magn Reson Imaging"},{"key":"R7-20250807","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0720-048X(02)00271-1","article-title":"Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging.","volume":"44","author":"Akenaka","year":"2002","journal-title":"Eur J Radiol"},{"key":"R8-20250807","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0720-048X(98)00167-3","article-title":"MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence.","volume":"29","author":"Hatabu","year":"1999","journal-title":"Eur J Radiol"},{"key":"R9-20250807","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157340512800672216","article-title":"MRI of focal liver lesions.","volume":"8","author":"Albiin","year":"2012","journal-title":"Curr Med Imaging Rev"},{"key":"R10-20250807","first-page":"769753","article-title":"Imaging of spinal metastatic disease.","volume":"2011","author":"Shah","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"R11-20250807","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejrad.2005.01.019","article-title":"Whole-body MR imaging of bone marrow.","volume":"55","author":"Schmidt","year":"2005","journal-title":"Eur J Radiol"},{"key":"R12-20250807","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00259-023-06308-y","article-title":"PET\/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL).","volume":"50","author":"Prakken","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20250807","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s00259-020-04801-2","article-title":"Prospective evaluation of whole-body MRI and (18)F-FDG PET\/MRI in N and M staging of primary breast cancer patients.","volume":"47","author":"Bruckmann","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-20250807","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/RLU.0000000000003488","article-title":"Prospective correlation of prognostic immunohistochemical markers with SUV and ADC derived from dedicated hybrid breast 18F-FDG PET\/MRI in women with newly diagnosed breast cancer.","volume":"46","author":"Morawitz","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R15-20250807","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cpet.2016.05.008","article-title":"Clinical PET-MR imaging in breast cancer and lung cancer.","volume":"11","author":"Rice","year":"2016","journal-title":"PET Clin"},{"key":"R16-20250807","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejrad.2015.12.010","article-title":"Evaluation of (18)F-FDG PET\/MRI, (18)F-FDG PET\/CT, MRI, and CT in whole-body staging of recurrent breast cancer.","volume":"85","author":"Sawicki","year":"2016","journal-title":"Eur J Radiol"},{"key":"R17-20250807","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/diagnostics5030333","article-title":"PET\/MRI in oncological imaging: state of the art.","volume":"5","author":"Bashir","year":"2015","journal-title":"Diagnostics (Basel)"},{"key":"R18-20250807","first-page":"172","article-title":"Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.","volume":"6","author":"Raman","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"R19-20250807","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3174\/ajnr.A7464","article-title":"PET\/MRI in pediatric neuroimaging: primer for clinical practice.","volume":"43","author":"Pedersen","year":"2022","journal-title":"Am J Neuroradiol"},{"key":"R20-20250807","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00261-015-0474-0","article-title":"Comparison of hybrid FDG PET\/MRI compared with PET\/CT in colorectal cancer staging and restaging: a pilot study.","volume":"40","author":"Paspulati","year":"2015","journal-title":"Abdom Imaging"},{"key":"R21-20250807","doi-asserted-by":"crossref","first-page":"e200091","DOI":"10.1148\/rycan.2021200091","article-title":"Measuring glucose uptake in primary invasive breast cancer using simultaneous time-of-flight breast PET\/MRI: a method comparison study with prone PET\/CT.","volume":"3","author":"Fowler","year":"2021","journal-title":"Radiol Imaging Cancer"},{"key":"R22-20250807","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2016151155","article-title":"Comparison of whole-body 18F FDG PET\/MR imaging and whole-body 18F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer.","volume":"281","author":"Melsaether","year":"2016","journal-title":"Radiology"},{"key":"R23-20250807","doi-asserted-by":"crossref","first-page":"e0137285","DOI":"10.1371\/journal.pone.0137285","article-title":"Accuracy of [18F]FDG PET\/MRI for the detection of liver metastases.","volume":"10","author":"Beiderwellen","year":"2015","journal-title":"PLoS One"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:04:01Z","timestamp":1754597041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001900","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}